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ABSTRACT

Liver regeneration is a complex process that requires the coordinated expression
of cytokines and growth factors. One well-studied model of liver regeneration is partial
hepatectomy (PH), in which removal of 70% of the liver initiates compensatory
hepatocyte proliferation. PH-induced liver regeneration requires the activation of
resident macrophages (Kupffer cells), which produce cytokines that drive hepatocyte
proliferation. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that is
known to activate macrophages and recruit monocytes during tissue injury. The goal of
this study was to determine how MCP-1 contributes to macrophage activation during
liver regeneration. Results indicate that hepatic and plasma MCP-1 levels increased
within 12 hr after PH and correlated with hepatic recruitment of cells expressing the
MCP-1 receptor, CCR2. Nevertheless, hepatocyte proliferation was comparable in MCP1 knockout and wild-type mice, as was the expression of Kupffer cell-derived cytokines.
Furthermore, hepatic recruitment of CCR2+ cells was similar in MCP-1 knockout and
wild-type mice, which suggests that other chemokines may efficiently recruit CCR2+
cells in the absence of MCP-1. CCR2 appears to be required for optimal regeneration, as
CCR2 knockout mice had levels of hepatocyte proliferation that were 50% lower than
wild-type mice 36 hr after PH. We conclude that MCP-1 is not required for macrophage
activation during PH-induced liver regeneration. Future studies should instead focus on
mechanisms by which CCR2 signaling events and the hepatic recruitment of CCR2expressing cells facilitates hepatocyte proliferation during liver regeneration.
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CHAPTER 1: INTRODUCTION

Overview
Liver regeneration is an amazing phenomenon, in which removal of a portion of
the liver induces remaining cells to proliferate to restore organ mass. The capacity of the
liver to regenerate has been recognized for thousands of years. In fact, it is referenced in
the Greek myth of Prometheus, who was a titan accused of stealing fire from the gods of
Mount Olympus. As punishment for his treachery, Prometheus was tied to a rock, and
his liver was eaten by an eagle each day only to grow back during the night, thus causing
perpetual torment (Power & Rasko, 2008).
While the human liver does not actually regenerate overnight, it does have the
capacity to restore its mass and function within just a few months after widespread
damage or tissue loss (Aoki et al., 2011). The physiology of liver regeneration has been
extensively investigated, but it is still not completely understood. For example, the
precise mechanisms that initiate and terminate regeneration have yet to be identified.
Furthermore, the identification of these mechanisms is confounded by pathological
factors, such as inflammation or viral disease, which often accompany human liver
disease.

Liver Anatomy and Physiology
The liver performs several essential physiological functions. One major function
of the liver is to synthesize proteins. In fact, almost all of the major plasma proteins are
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produced in the liver. These proteins include albumin, which is essential for maintaining
osmotic pressure in the circulatory system, as well as transferrin, prothrombin,
fibrinogen, lipoproteins and complement proteins. The liver also functions in regulation
of lipid, protein and glucose metabolism (Tacke, Luedde, & Trautwein, 2009), and it is
richly populated with immune cells, allowing it to participate in both innate and adaptive
immune responses (Tacke et al., 2009). Finally, perhaps the most recognized function of
the liver is detoxification of exogenous and endogenous compounds via the induction of a
wide array of xenobiotic metabolizing enzymes, such as the cytochrome P450 enzyme
family (Hakkola, Tanaka, & Pelkonen, 1998).

Blood Flow Through the Liver
The liver is a highly perfused organ. Nutrient-rich blood from the gastrointestinal
tract is routed to the liver through the hepatic portal vein, whereas oxygen-rich blood is
delivered to the liver through the hepatic artery (Fig. 1.1). Portal blood mixes with
arterial blood in small, permeable capillaries, known as sinusoids, which permeate the
liver. Sinusoids deliver blood to the hepatocytes, enabling them to carry out metabolic
processes. Blood then empties into central veins that coalesce into the hepatic vein, which
returns blood to the systemic circulation (Wheatley et al., 1997).
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Figure 1.1
Blood Flow Through the Liver. Oxygenated blood is carried to the liver
through the hepatic artery. Nutrient-rich, oxygen-poor blood is delivered from the
intestines to the liver though the portal vein. Blood mixes in small, permeable capillaries
known as sinusoids. The sinusoids allow blood to flow from the portal triads to the
central veins, which coalesce and drain into the hepatic vein, which returns blood to the
systemic circulation.
Bile Production
In addition to receiving a dual blood supply, another interesting feature of the
liver is its role in producing bile. Hepatocytes use cholesterol to synthesize bile, which
helps emulsify fats in the small intestine (Chiang, 2009). Bile is collected from all areas
of the liver through bile ductules, which coalesce and exit the liver through the common
bile duct. The liver architecture is divided into lobules, with each lobule receiving blood
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and producing bile. The lobules intersect each other at structures called portal triads,
which consist of branches of the hepatic portal vein and hepatic artery, as well as a bile
ductule (Fig. 1.1). The abundance of portal triads throughout the liver ensures adequate
perfusion of blood and efficient collection of bile.

Hepatocytes
The most common cell in the liver is the parenchymal hepatocyte, which
comprises 60% of all liver cells and 80% of the liver volume (Ramadori & Saile, 2002).
Hepatocytes are a specialized type of epithelial cell that stack tightly together to form
plates that are separated by sinusoids. Hepatocytes are polarized and have distinct apical,
lateral, and basal surfaces that aid in uptake and secretion of substances. The basal
surface of the hepatocyte faces the sinusoid and contains microvilli that increase surface
area to facilitate exchange of materials. The apical surface also has many microvilli and
faces the bile canaliculi (Ramadori & Saile, 2002). The lateral surfaces of hepatocytes
are connected by gap junctions to allow the flow of molecules between cells.
Hepatocytes perform the bulk of liver functions including detoxification and plasma
protein production.

Nonparenchymal Cells
While the most abundant type of cell in the liver is the parenchymal hepatocyte,
other non-parenchymal cells exist and are important for liver homeostasis. Nonparenchymal cells comprise 35% of all liver cells and include sinusoidal endothelial cells,
resident macrophages, hepatic stellate cells, and biliary epithelial cells, which are also
called cholangiocytes (Fig. 1.2). Other less abundant non-parenchymal cells include
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immune cells, such as resident T cells and natural killer cells. Non-parenchymal cells
contribute to liver homeostasis through diverse mechanisms, such as regulation of blood
flow, bile transport, vitamin A storage, and immune surveillance.

Liver Sinusoid Endothelial Cells
Liver sinusoid endothelial cells line the capillary sinusoids. These cells are highly
fenestrated, which allows blood to easily exit the capillary lumen and bathe the
surrounding sheets of hepatocytes, where nutrients and soluble factors are exchanged.
Following liver injury, these cells are capable of proliferating, and additional progenitors
are recruited from the bone marrow (DeLeve, 2013). During liver regeneration, sinusoid
endothelial cells not only proliferate, but also secrete soluble mediators, such as
hepatocyte growth factor, which is a mitogen for hepatocyte proliferation.

Hepatic Stellate Cells
Hepatic stellate cells (HSC) reside between the LSEC and hepatocytes in an area
referred to as the space of Disse. In the healthy liver, HSCs store 80% of the body’s
vitamin A as retinol esters (Friedman, 2008). However, liver injury may induce these
cells to assume a myofibroblast-like phenotype, characterized by the production of
extracellular matrix proteins, such as collagen type I. Indeed, HSCs are central to the
wound healing response, and inappropriate activation of these cells plays a central role in
the development of liver fibrosis (Kawser, Iredale, Winwood, & Arthur, 1998). During
liver regeneration, HSCs are thought to be an abundant producer of hepatocyte growth
factor (Skrtic et al., 1997).

6
Biliary Epithelial Cells
Biliary epithelial cells are non-parenchymal cells that line the bile ducts that
transport bile to the small intestine (Katayanagi, Kono, & Nakanuma, 1998). These cells
are cuboidal epithelial cells that have been shown to secrete cytokines (Isse, Harada, &
Nakanuma, 2007; Katayanagi et al., 1998). These cells have been shown to proliferate
and recruit leukocytes during several pathological conditions of the liver (Isse et al.,
2007).

Immune Cells of the Liver
Immune cells are an important component of the liver. Because blood is
delivered directly from the gastrointestinal tract to the liver, the liver is tasked with
removing foreign substances and potential pathogens from the blood before it reaches the
systemic circulation. Resident immune cells, such as T and B lymphocytes, natural killer
cells, and macrophages, are crucial for removing pathogens and initiating an adaptive
immune response, if necessary.
Resident macrophages in the liver, also known as Kupffer cells (KC), line the
sinusoids and scavenge particulate debris in blood that enters the liver. They are derived
from circulating monocytes. These cells play a critical role in detoxifying blood from the
portal circulation. In fact, large periportal KC are the first cells to encounter pathogens
that reach the liver through the portal vein. Upon contact with pathogens, KC become
activated and secrete soluble mediators, such as tumor necrosis factor-α (TNFα),
prostaglandin-E2, and interleukin (IL)-1. Smaller KC are located near the central vein of
liver lobules (Bilzer, Roggel, & Gerbes, 2006). Although KC typically reside in the liver
for up to 14 months, they are capable of replication (Dory et al., 2003). Also, KC
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numbers can be replenished when circulating monocytes enter the liver and differentiate
into macrophages. During liver regeneration, macrophages are critical sources of IL-6
and TNFα, which are necessary for hepatocyte proliferation (Selzner et al., 2003).

Figure 1.2
Cells of the Liver. The liver is comprised of several cell types.
Parenchymal hepatocytes are arranged in sheets that are lined by sinusoidal capillaries.
The sinusoidal epithelium is highly fenestrated and is lined with endothelial cells.
Hepatic stellate cells are non-parenchymal cells found in the space of Disse between the
hepatocytes and sinusoids. Macrophages known as Kupffer cells line the sinusoidal
endothelium.
Regenerative Ability of the Liver
The liver is constantly exposed to foreign material and potentially toxic
chemicals, as it receives blood from the stomach and intestines. Nevertheless,
mammalian hepatocytes typically have low turnover (Malato et al., 2011). However,
hepatocyte proliferation may be induced depending on the severity of the insult. The
regenerative capacity of the liver may have evolved as protection against ingested
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toxicants (Taub, 2004). This regenerative process appears to depend on a complex
symphony of soluble mediators and cellular events and has been well studied in animal
models of partial hepatectomy (PH), in which a substantial portion (usually 70-80%) of
the liver is resected. After PH, resident nonparenchymal cells produce soluble mediators
that signal the hepatocytes, as well as other cells in the liver, to proliferate in a fairly
synchronized manner and restore liver mass.
It is a hotly debated issue whether stem cells exist in the liver, and if so, how
extensively they contribute to regeneration. Observation of hepatocytes moving from
periportal to centrilobular locations during maturation has been interpreted by some to be
evidence of a stem cell population in the periportal region of the lobule (Sigal et al.,
1995). Despite the continual research to discover a population of stem cells in the liver, it
has been shown that existing, mature hepatocytes can replicate and restore liver mass
without the involvement of stem cells (Sharma, Cantz, Manns, & Ott, 2006).
One model system that demonstrates the proliferative capacity of mature
hepatocytes is fumarylacetoacetate hydrolase-deficient mice (Overturf, AlDhalimy, Ou,
Finegold, & Grompe, 1997). Fumarylacetoacetate hydrolase is an enzyme that catalyzes
the hydrolysis of 4-fumarylacetoacetate into fumarate and acetoacetate. Without this
enzyme, buildup of toxic metabolites leads to progressive liver damage and cell loss.
When a small number of healthy adult hepatocytes were transplanted into the liver of
fumarylacetoacetate hydrolase-deficient mice, the cells completely repopulated the liver
and restored liver function (Overturf et al., 1997). In fact, it was found that the cells
could be serially transplanted from one enzyme-deficient mouse to another, which
demonstrates the nearly limitless proliferative capacity of adult hepatocytes.
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Liver regeneration following PH is referred to as compensatory regeneration, in
which cells proliferate to restore lost organ mass. Compensatory hyperplasia occurs when
large areas of the liver are damaged or physically removed. A physiologically relevant
event that could lead to compensatory hyperplasia is widespread liver necrosis due to the
effects of a toxicant. However, in the laboratory, surgical resection of the liver is
typically preferred to chemical-induced necrosis for inducing regeneration because the
excessive inflammatory response associated with necrosis can be a confounding factor in
understanding normal regenerative processes.
Compensatory regeneration should not be confused with two other types of
regeneration: mitogen-induced hyperplasia and leading edge regeneration. Mitogeninduced hyperplasia refers to hepatocyte proliferation that occurs in response to mitogens
in the absence of tissue injury or loss (Columbano et al., 1990). In this type of
hyperplasia, hepatocytes must overcome normal growth control mechanisms to
proliferate, and under such conditions, the increased liver mass is called “augmentative
hepatomegaly” (Michalopoulos, 2013). When the mitogen is removed, the original organ
mass is restored as excess cells undergo apoptosis (Columbano, Leddacolumbano, Lee,
Rajalakshmi, & Sarma, 1987). Whereas the liver can undergo compensatory regeneration
and mitogen-induced hyperplasia, it does not participate in leading-edge regeneration, in
which only those cells that are positioned along a damaged edge of a tissue are capable of
dividing. A classic example of leading edge regeneration is limb regeneration in
salamanders, in which amputation of the limb results in regrowth of the entire limb. This
process is also analogous to limb development during embryogenesis (Nacu & Tanaka,
2011).
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PH Model of Liver Regeneration
The 70% PH model has been extensively used to investigate mechanisms of liver
regeneration (Michalopoulos, 2010). In mice, 70% PH consists of surgical resecting
three of the five main liver lobes (Greene & Puder, 2003). Following resection,
parenchymal and non-parenchymal cells in the remnant liver proliferate in a fairly
synchronized manner. Peak DNA synthesis in hepatocytes occurs within 24 hours in rats
and 36 hours in mice (Mao, Glorioso, & Nyberg, 2014; Michalopoulos & DeFrances,
1997). The precise mechanisms by which liver regeneration is regulated, including the
onset and termination of regeneration, are poorly understood. Once the mass of the liver
is restored, cells presumably receive signals that terminate their proliferation. The
proliferative process typically results in a slight overproduction of liver cells but is
followed by a wave of apoptosis, which restores the liver to within 5% of its previous
mass (Michalopoulos, 2013).

Phases of Liver Regeneration
Liver regeneration can be divided into two phases, referred to as priming and
progression (Fig. 1.3), both of which are required for complete regeneration (Fausto,
2000). Priming refers to a collection of events that culminate in the movement of
quiescent liver cells into the cell cycle, whereas progression refers to those events that
facilitate continued progression through the cell cycle, resulting in actual cell division.

Priming and Progression of Liver Regeneration
Hepatocyte priming is mediated by the production of TNFα and IL-6 by Kupffer
cells (Baier et al., 2005). These soluble mediators bind to their cognate receptors on
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hepatocytes and induce the activity of transcription factors, such as NF-kB, STAT3, AP1,
and CF/EBP-beta (Kountouras, Boura, & Lygidakis, 2001). Changes in hepatocyte gene
expression prepare these cells to respond to growth factors produced during the
progression phase of regeneration. For example, hepatocytes upregulate c-Met, which is
the receptor for hepatocyte growth factor, and EGFR, which is the receptor for epidermal
growth factor (Su, Guidotti, Pezacki, Chisari, & Schultz, 2002). During the progression
phase of regeneration, hepatocyte replication is dependent on the availability of these
growth factors, as well as other soluble mediators (Fausto, Campbell, & Riehle, 2006).

Termination of Liver Regeneration
Termination of liver regeneration is precisely regulated, yet the mechanisms that
halt hepatocyte proliferation are poorly understood. Previous research implicated TGF-β
due to its well known antiproliferative activity, but this has not been definitely proven
(Macias-Silva, Li, Leu, Crissey, & Taub, 2002). Recent evidence suggests a possible role
for caspases, which are cysteine-aspartic proteases important for apoptosis, necrosis, and
inflammation (Alnemri et al., 1996). For example, caspase recruitment domaincontaining protein-11 was recently found to be upregulated during termination of liver
regeneration (Nygard et al., 2012). Nevertheless, the exact molecular mechanisms of this
termination phase remain unclear.
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Figure 1.3
Phases of Liver Regeneration. In the healthy liver, hepatocytes are
quiescent. Removal of a substantial portion of the liver through PH induces macrophages
to produce TNFα and IL-6, which primes the hepatocytes for subsequent progression
through the cell cycle, which is dependent on growth factors, such as hepatocyte growth
factor (HGF) and epidermal growth factor (EGF).
Monitoring Liver Regeneration
Several methods can be used to monitor progression of liver regeneration. A
common measure is liver weight and the liver-body weight ratio. While this method is
straightforward, it can be influenced by factors not directly related to regeneration, such
as glycogen and lipid content in the liver, as well as blood volume. A commonly used
approach for measuring liver regeneration is quantifying the number of proliferating
hepatocytes. This is often accomplished through the administration of the nucleotide
analog bromodeoxyuridine (BrdU), which is incorporated into the newly synthesized
DNA strand in place of thymidine (Assy & Minuk, 1997). BrdU incorporation indicates
that a hepatocyte has progressed to S-phase of the cell cycle and has successfully
duplicated its DNA. BrdU incorporation is typically quantified in hepatocytes using flow
cytometry or immunohistochemistry.
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Role of Macrophages in Liver Regeneration

Macrophage Numbers Increase Following PH
In healthy liver tissue, KC make up the largest population of nonparenchymal
cells. These liver cells maintain their population by self-renewal and also via recruitment
of monocytes from the bone marrow or spleen (Naito, Hasegawa, & Takahashi, 1997).
Following PH, the number of KC in the liver increases within 1 hour (Baier et al., 2005).
There is another increase in the number of KC 6-12 hr following PH, and this increase is
comprised mainly of activated cells (Baier et al., 2005). It has been suggested that the
early increase in macrophage number is due to the recruitment of monocytes, which are
macrophage precursors, from the bone marrow (Minamino et al., 2012). The second
increase is believed to result from proliferation of activated resident macrophages (Ukai
et al., 1990).

Macrophages Become Activated After PH
It is hypothesized that changes in blood flow through the liver may be involved in
priming hepatocytes after PH (Michalopoulos, 2010; Mochida, Ohta, Ogata, & Fujiwara,
1992). After removal of 70% of the liver, blood from the portal vein and hepatic artery is
still being delivered to the liver at normal flow rates, despite the fact that the organ
volume is markedly decreased, which results in increased intrahepatic pressure.
Increased blood flow to the liver enhances the delivery of molecules that can potentially
activate resident KC, including bacterial lipopolysaccharide (LPS), which is known to
activate macrophages (Shiratori et al., 1996). In fact, LPS is a well-known inducer of
macrophage-derived IL-6 and TNFα, both of which are necessary for priming of
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hepatocytes immediately following liver regeneration (Fujihara et al., 2003). Increased
intrahepatic pressure following PH can also stimulate KC to secrete vasoactive factors,
such as heme oxygenase (HO)-1 and endothelial nitric oxide synthase (eNOS)
(Abshagen, Eipel, Kalff, Menger, & Vollmar, 2008). Kupffer cells are critical for
regulating vascular permeability in the liver (Abshagen et al., 2008). When KC are
depleted, blood flow in liver sinusoids during regeneration is decreased (Abshagen et al.,
2008). Hence, KC-mediated changes in microcirculation may be critical to initiation of
liver regeneration via increased intrahepatic pressure or enhanced delivery of LPS.

Macrophages Mediate the Priming Phase of Liver Regeneration
Cells of the monocyte-macrophage lineage are necessary for priming hepatocytes
during liver regeneration through the production of IL-6 and TNFα (Taub, 2004). First,
TNFα is secreted by KC in response to activation by the bacterial antigen, LPS. TNFα
functions in an autocrine fashion to stimulate IL-6 secretion. IL-6 binds to receptors on
the cell surface of hepatocytes. This leads to activation of STAT3, which is a
transcription factor that drives the expression of immediate early genes that drive
hepatocyte cell cycle progression. These events are summarized in Figure 1.4.
Numerous studies demonstrate that monocyte/macrophage-derived TNFα and IL6 are necessary for normal liver regeneration to proceed. For example, in one study, mice
were irradiated to destroy their immune cell populations, including monocytes and
macrophages (Sudo et al., 2008). Immune cells were repopulated through the transfer of
bone marrow from wild-type, TNFα knockout, or IL-6 knockout mice, and the mice were
subjected to PH. Mice that received bone marrow from TNFα or IL-6 knockout mice had
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decreased rates of hepatocyte DNA synthesis compared to those that received transplants
from wild-type mice.

Figure 1.4
KC Prime Hepatocytes to Enter the Cell Cycle. Upon activation, KC
secrete TNFα, which stimulates the secretion of IL-6. IL-6 binds to receptors on
hepatocytes and stimulates expression of genes necessary for hepatocyte cell cycle
progression.
Role of MCP-1 in Monocyte Recruitment and Macrophage Activation
During inflammatory responses, resident macrophages in injured tissue become
activated, and additional monocytes are recruited from the bone marrow and circulation
to the injured tissue, where they differentiate into activated macrophages. Monocyte
recruitment occurs in response to chemokines, which are proteins that regulate white
blood cell trafficking as well as inflammation (Mantovani et al., 2004; Rossi & Zlotnik,
2000). Chemokines are categorized based on the position of cysteine (C) residues at the
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N-terminus: CC, CXC, C, and CX3C (Deshmane, Kremlev, Amini, & Sawaya, 2009;
Mantovani et al., 2004).
The first human CC chemokine discovered was monocyte chemoattractant
protein-1 (MCP-1), also known as CC-chemokine ligand-2 (CCL2) (Yadav, Saini, &
Arora, 2010). Regulated at the transcriptional level, MCP-1 expression is induced by a
variety of stimuli, including LPS and changes in blood flow (Taub, 2004; Uguccioni,
Dapuzzo, Loetscher, Dewald, & Baggiolini, 1995). During liver regeneration, MCP-1
appears to be primarily produced by Kupffer cells, but it can also be secreted by hepatic
stellate cells and endothelial cells (Marra, 2002).
MCP-1 works through a G-protein coupled receptor, CCR2, which is expressed
on the surface of many leukocytes, including monocytes, T-cells, and NK cells
(Deshmane et al., 2009). Although at least three MCP-1 receptors exist, CCR2 is the
primary receptor for MCP-1 in mice (Charo et al., 1994). CCR2 is expressed on Kupffer
cells (Deshmane et al., 2009), which can be activated and recruited to sites of
inflammation by MCP-1 (Boring et al., 1997; Kurihara, Warr, Loy, & Bravo, 1997).
In the liver, MCP-1 expression is increased during chronic hepatitis, inflammation
and fibrosis (Czaja, Geerts, Xu, Schmiedeberg, & Ju, 1994; Marra, 2002; Marra et al.,
1998), and inactivation of MCP-1 has been shown to attenuate liver injury by inhibiting
macrophage recruitment (Imamura, Ogawa, Sasaguri, Chayama, & Ueno, 2005; Zamara
et al., 2007). Impaired monocyte migration has also been reported for mice that lack
CCR2 (Boring et al., 1997). However, little is known about the consequences of MCP1/CCR2 signaling during PH-induced liver regeneration.
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Hypothesis
Given the significance of MCP-1 to monocyte recruitment and macrophage
activation, we hypothesized that this chemokine is important for activating monocytes
and resident KC during liver regeneration. We took advantage of the availability of
transgenic mice to determine how MCP-1 expression and CCR2 expression contribute to
hepatocyte proliferation during PH-induced liver regeneration. The specific aims of the
study were as follows:
1) To characterize MCP-1 expression during liver regeneration in wild-type mice.
2) To determine if MCP-1/CCR2 is required for monocyte recruitment, macrophage
activation, and hepatocyte proliferation during liver regeneration.
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CHAPTER 2: MATERIALS AND METHODS

Mice
Female C57Bl/6 (wild-type), MCP-1 knockout (KO) (strain B6.129S4Ccl2tm1Rol/J), and CCR2 KO (strain B6.129S4-Ccr2tm1Ifc/J) mice were purchased from the
Jackson Lab (Bar Harbor, ME) and used at 8-9 weeks of age. MCP-1 and CCR2 KO
mice are fertile and display no gross physical or behavioral abnormalities. Furthermore,
numbers of macrophages (peritoneal, alveolar, and Kupffer cells) in these KO mice are
similar to levels found in wild type mice (Boring et al., 1997; Lu et al., 1998). Mice were
housed in a temperature-controlled facility on a 12-hr light/dark cycle with unlimited
access to food and water. Mice were anesthetized with inhaled isoflurane, and 70% PH
was performed as previously described (Mitchell, Lockhart, Huang, & Elferink, 2006).
After euthanasia, blood was collected at the axillary plexus, plasma was recovered by
centrifugation, and remnant liver tissue was collected. The experimental protocol was
approved by the Animal Studies Subcommittee and the Research and Development
Committee of the Boise VA Medical Center (Boise, ID), where the animals were housed.
All animals received humane care according to the criteria outlined in the "Guide for the
Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and
published by the National Institutes of Health.
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Measurement of MCP-1 Levels
At each time point, tissues from 3–5 mice were used to measure MCP-1 mRNA
levels in the liver and MCP-1 protein levels in liver homogenates and plasma. To
measure hepatic MCP-1 mRNA levels, total RNA was isolated from frozen liver tissue
using an RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer’s
protocol. cDNA was synthesized using SuperScript II reverse transcriptase (Invitrogen,
Carlsbad, CA). Transcript levels were measured by quantitative real-time PCR (qRTPCR) at the Molecular Genomics Core at the University of Texas Medical Branch
(Galveston, TX). To measure MCP-1 protein levels in the liver, frozen liver tissue was
homogenized in PBS containing 0.5% Triton X-100 0.05% sodium azide, and protease
inhibitors. MCP-1 levels were measured in liver homogenates by ELISA (Thermo
Scientific Pierce, Rockford, IL) and expressed as pg per mg liver protein, based on a
Lowry protein assay (Bio-Rad, Hercules, CA). Plasma levels of MCP-1 were measured
using a Cytometric Bead Array (BD Biosciences, San Diego, CA) according to the
manufacturer’s instructions. Unpooled plasma samples were run in duplicate.
Quantification of F4/80+ Cells by Immunohistochemistry
Paraffin-embedded liver tissue was incubated with proteinase K for 3 minutes to
retrieve antigen. Tissue was then incubated overnight with a biotinylated rat-anti-mouse
F4/80 antibody (Invitrogen, Carlsbad, CA) and visualized using an anti-rat HRP-DAB
Cell and Tissue Staining Kit (R&D Systems, Minneapolis, MN). Eight fields of 400X
magnification were counted from each mouse.
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Measurement of TNFα and IL-6 Production by ELISA
Levels of TNFα and IL-6 were measured in unpooled plasma samples using
sandwich enzyme-linked immunosorbent assay kits (Pierce Biotech, Rockford, IL). The
assays were performed according to the manufacturer’s instructions, and all samples were
run in duplicate. The lower limit of detection for the assays was 50 pg/ml.

Measurement of Stat3 Activation by Western Blot
Frozen liver tissue was mechanically homogenized as described elsewhere
(Mitchell et al., 2006). Cellular debris was pelleted at 10,000 X g, and protein
concentration was determined by using a Lowry protein assay (Bio-Rad, Hercules, CA).
Homogenates (25-50 µg protein/lane) were fractionated by SDS-PAGE and transferred to
polyvinylidene difluoride membranes for western blot analysis with anti-STAT3 and antiphosphorylated STAT3 antibodies (Cell Signaling Technology, Danvers, MA).

BrdU Labeling and Detection
To measure hepatocyte proliferation, mice were injected intraperitoneally with 50
mg/kg bromodeoxyuridine (BrdU; Sigma-Aldrich, St. Louis, MO) two hours prior to
euthanasia. In a separate experiment, continuous BrdU labeling was achieved by
administering BrdU in the drinking water (0.8 mg/ml). Water bottles containing BrdU
were protected from light and replenished daily until mice were killed 6 days
postoperatively. After euthanasia, fresh liver tissue was fixed in UltraLight™ fixative
(Bi-Biomics, Nampa, ID), paraffin-embedded, and processed for immunohistochemical
staining. Tissue sections (5-um) were incubated with a biotinylated anti-BrdU antibody
(Invitrogen, Carlsbad, CA) followed by avidin-conjugated horseradish peroxidase and the
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substrate 3,3’-diaminobenzidine (DAB). Sections were counterstained with hematoxylin.
For each animal, at least five random 400X fields were examined, and a total of 800-1000
nuclei were counted. The number of brown (DAB)-stained nuclei (BrdU+) was
expressed as a percentage of total number of nuclei.
Detection of CCR2+ Cells by Immunofluorescence Staining
Paraffin-embedded tissue sections (5-µm) were processed and cut for
immunofluorescence staining. Antigen retrieval was carried out in sodium citrate buffer
at 95°C for 15 minutes. Sections were incubated with a rabbit monoclonal anti-CCR2
antibody (Novus, Littleton, CO) followed by a FITC-conjugated goat anti-rabbit antibody
(BD Biosciences, San Diego, CA). CCR2+ cells were visualized using a fluorescent
microscope.
Detection of CCR2+ Cells by Flow Cytometry
Nonparenchymal cells were isolated from the liver and analyzed by flow
cytometry. Briefly, livers were perfused with Hank’s Buffered Salt Solution (HBSS)
containing 50 mM EDTA, transferred to RPMI 1640 with 2.5% FBS, minced into a
slurry, and poured through a nylon cell strainer. Samples were centrifuged at 60 x g for 1
min at room temperature (RT), and pellets containing hepatocytes were discarded.
Samples were then centrifuged at 500 x g for 10 min at room temperature. Resulting
pellets were re-suspended in Percoll in RPMI 1640 without FBS and centrifuged at 850 x
g, 30 min at room temperature. Pellets were depleted of red blood cells by hypotonic
lysis, and remaining cells were resuspended in PBS containing 1% fetal bovine serum.
Cells were then incubated with Fc-Receptor Block (BD Biosciences, San Jose, CA) for 10

22
min before staining with a rabbit monoclonal anti-CCR2 antibody (Novus, Littleton, CO)
followed by a FITC-conjugated goat anti-rabbit antibody (BD Biosciences, San Diego,
CA). Stained cells were analyzed on an Accuri C6 flow cytometer (Ann Arbor, MI). At
least 50,000 events (viable cells) were collected from unpooled samples and analyzed
using Accuri CFlow Plus software.

Statistical Analysis
Data were analyzed using Prism (version 4.0, GraphPad Software, San Diego, CA).
Data were evaluated by one-way ANOVA followed by a Dunnett’s post-hoc test, or by
two-way ANOVA and Bonferroni post-hoc test. Data were considered significantly
different at p ≤ 0.05.
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CHAPTER 3: RESULTS

MCP-1 Levels Increase After PH
To examine MCP-1 production after PH, MCP-1 mRNA levels were quantified in
the remnant liver, and protein levels were measured in liver homogenates and plasma.
Hepatic MCP-1 mRNA levels peaked 90 minutes after PH (Fig. 3.1A), followed by
increased MCP-1 protein expression in the regenerating liver 4 hr and 6 hr after PH (Fig.
3.1B). A four-fold increase in circulating MCP-1 was detected in the plasma 12 hr after
PH (Fig. 3.1C).

Figure 3.1
MCP-1 Levels Increase After PH. A: MCP-1 mRNA levels in the
regenerating liver at the indicated times after PH. MCP-1 mRNA levels (mean +/- SEM)
are expressed as fold-induction relative to expression of 18S rRNA in the same samples
(n=3). B: MCP-1 protein levels in the liver after PH. MCP-1 levels (mean +/- SEM) in
liver homogenates were normalized to the total amount of protein in each sample (n=3-5).
C: MCP-1 protein levels (mean +/- SEM) in the plasma after PH (n=3-6). * P < 0.05
when compared to 0-hr group based on one-way ANOVA followed by Dunnett’s test.
MCP-1 is Not Required for Recruitment of Hepatic F4/80+ Macrophages
It has been demonstrated that hepatic-derived MCP-1 stimulates the expansion and
egress of a population of F4/80+ monocytes in the bone marrow (Crane, HokenessAntonelli, & Salazar-Mather, 2009). Hence, we hypothesized that MCP-1 is important for
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recruiting bone marrow-derived monocytes to the regenerating liver and that numbers of
hepatic macrophages would be decreased in the absence of MCP-1. Using wild type and
MCP-1 knockout (KO) mice, we performed a cursory examination of liver macrophages
based on expression of F4/80 antigen. Contrary to our hypothesis, no changes in F4/80
expression were detected in the regenerating liver of wild type and MCP-1 KO mice (Fig.
3.2).

Figure 3.2
Number of Macrophages is Similar in the Liver of Wild Type and
MCP-1 KO Mice. Data represent average number of F4/80+ cells (+/- SEM) in the
regenerating liver of wild type and MCP-1 knockout mice at the indicated times after PH.
The number of F4/80+ cells was counted in 8 separate 40x fields per mouse from 3-5
mice per treatment group.
MCP-1 is Not Required for TNFα or IL-6 Production During Liver Regeneration
During the priming phase of liver regeneration, the production of TNFα and IL-6 is
attributed to activated Kupffer cells (Taub, 2004). Kupffer cells express the MCP-1
receptor, CCR2, and have been shown to become activated in response to MCP-1 in other
model systems (Marra, 2002). Hence, we hypothesized that MCP-1 may influence the
production of Kupffer cell-derived cytokines during liver regeneration. However,
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measurement of plasma cytokine levels revealed no difference in TNFα or IL-6 production
between wild type and MCP-1 KO mice (Fig. 3.3). Hepatic mRNA levels of these
cytokines were below the limit of detection (data not shown).

Figure 3.3
Levels of Kupffer Cell-Derived Cytokines are Similar in Wild Type
and MCP-1 KO Mice. Data represent plasma levels (mean +/- SEM) of TNFα and IL-6
in wild type and MCP-1 KO mice at the indicated times after PH. Cytokines were
measured in unpooled plasma samples by ELISA (n=3-5) and run in duplicate.
MCP-1 is Not Required for Priming of Hepatocytes During Liver Regeneration
The production of TNFα and IL-6 by Kupffer cells is implicated in priming
hepatocytes for cell cycle progression (Aldeguer et al., 2002). Upon binding to its cognate
receptor on hepatocytes, IL-6 activates Stat3 signaling pathways, leading to gene
expression that facilitates hepatocyte proliferation. Hence, Stat3 activation is a pivotal
step in regeneration that is likely to be dependent on macrophage activation. Our results
indicate that hepatic levels of phosphorylated Stat3 increased 6 and 12 hr after PH in both
wild type and MCP-1 KO mice, suggesting that MCP-1 is not necessary for hepatocyte
priming during liver regeneration (Fig. 3.4).

26

Figure 3.4
MCP-1 is Not Required for Stat3 Activation During Liver
Regeneration. Representative western blot analysis of Stat3 and phosphorylated-Stat3
proteins in the regenerating liver of wild type and MCP-1 KO mice at the indicated times
after PH (20 µg protein/lane).
MCP-1 is Not Required for Hepatocyte Proliferation After PH
Finally, we investigated the ramifications of MCP-1 production on the regenerative
capacity of the liver. No differences in liver-body weight ratios were detected between
wild type and MCP-1 KO mice (Fig. 3.5A). Pulse labeling with BrdU revealed that robust
hepatocyte proliferation occurred 36 and 48 hr after PH in wild-type mice and was not
suppressed in MCP-1 KO mice (Fig. 3.5B). Likewise, continuous BrdU administration
revealed no overt differences in BrdU incorporation in the regenerating liver of wild type
and MCP-1 KO mice 6 days post-PH (Fig. 3.5C and 3.5D).
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Figure 3.5
MCP-1 is Not Required for Hepatocyte Proliferation After PH. A:
Liver-body weight ratios (mean +/- SEM) of wild type and MCP-1 KO mice at the
indicated times after PH (n=4-10). B: Percentage (mean +/- SEM) of BrdU+ hepatocyte
nuclei from wild type or MCP-1 KO mice at the indicated times after PH. Mice were
pulsed with BrdU 2 hr prior to euthanasia at the indicated time points (n=6-10). C:
Representative BrdU incorporation in regenerating liver tissue from wild type and MCP1 KO mice 6 days after PH; BrdU was added to the drinking water continuously for 6
days. D: Cumulative BrdU incorporation in the regenerating liver of wild type and MCP1 KO mice administered BrdU in their drinking water for 6 days post-PH. Data represent
the percentage (mean +/- SEM) of BrdU+ hepatocyte nuclei from 4 mice per treatment
group.
MCP-1 is Not Required for Recruitment of CCR2+ Cells to the Regenerating Liver
In addition to activating resident macrophages, MCP-1 may also recruit cells, such
as bone-marrow-derived monocytes, to the damaged liver (Liaskou et al., 2012). To
investigate the possibility that cell recruitment was diminished in the absence of MCP-1,
the prevalence of CCR2+ cells in the regenerating liver was measured.
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Immunofluorescence staining revealed equivalent numbers of CCR2+ cells in the liver of
wild-type and MCP-1 KO mice 12 hr after PH (Fig. 3.6A). This finding was confirmed
using flow cytometry, which revealed no changes in either the percent or total number of
CCR2+ non-parenchymal cells in wild-type and MCP-1 KO mice (Fig. 3.6B).

Figure 3.6
MCP-1 is Not Required for Recruitment of CCR2+ Cells to the
Regenerating Liver. A: Fluorescence microscopy was used to identify CCR2 expression
in the liver of wild type and MCP-1 KO mice 12 hr after PH. B: Flow cytometry was
used to measure CCR2 expression in non-parenchymal cells isolated from the
regenerating liver of wild type and MCP-1 KO mice 12 hour after PH. Data represent the
mean percentage and number (±SEM) of CCR2+ cells (n=4).
Hepatocyte Proliferation is Suppressed in CCR2-Deficient Mice
While MCP-1 is the most potent ligand of CCR2, there is redundancy in
chemokine signaling such that MCP-3 and MCP-5 also bind this receptor, which could
explain why liver regeneration was not impaired in the absence of MCP-1. To investigate
the collective contribution of all CCR2 chemokines to regeneration, we compared PHinduced hepatocyte proliferation between CCR2 KO and wild-type mice. As shown in
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Figure 3.7, levels of BrdU incorporation were reduced by about 40% in CCR2 KO mice
36 hr after PH, although no statistically significant suppression was observed at 48 hr
Reduced hepatocyte proliferation at 36 hr did not coincide with diminished liver-body
weight ratios, which remained similar in CCR2 KO and wild-type mice at every time point
tested.

A

B

Figure 3.7
Hepatocyte Proliferation is Suppressed in CCR2-Deficient Mice. A:
Percentage (mean +/- SEM) of BrdU+ hepatocyte nuclei from wild type or CCR2 KO
mice at the indicated times after PH. Mice were pulsed with BrdU 2 hr prior to
euthanasia at the indicated time points (n=3-4). B: Liver-body weight ratios (mean +/SEM) of wild type and CCR2 KO mice at the indicated times after PH. * p<0.05 when
compared to wild-type mice at same time point.
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CHAPTER 4: DISCUSSION

Macrophage activation is a crucial component of the early phase of liver
regeneration following PH (Taub, 2004). Given the well-characterized role of MCP-1 in
activating macrophages and promoting macrophage infiltration, we hypothesized that
MCP-1 would be important for macrophage activation during PH-induced liver
regeneration. However, data presented herein refute this hypothesis and demonstrate
that, despite increased hepatic levels of MCP-1 after PH, this chemokine is not required
for the production of macrophage-derived inflammatory cytokines or for hepatocyte
proliferation.
Increased MCP-1 expression has been observed in numerous models of liver
injury and disease, such as administration of concanavalin A, carbon tetrachloride, and
acetaminophen (Ajuebor, Hogaboam, Le, & Swain, 2003; James et al., 2005; Zamara et
al., 2007). Our results indicate that MCP-1 transcript levels increased just 90 min after
PH, which confirms another report (Su et al., 2002). Peak plasma levels of MCP-1 were
detected at 12 hr in our study and were only slightly above basal levels. It is unlikely that
robust expression of MCP-1 occurs in the plasma before this time, as a recent report by
Sgroi et al. demonstrates only scant levels of MCP-1 4 hr post-PH (Sgroi et al., 2011).
Although Kupffer cells are a known source of MCP-1, it is likely that multiple cellular
sources of MCP-1 exist in the regenerating liver (Hildebrand et al., 2006). For instance,
in a rat model of PH-induced liver regeneration, elevated MCP-1 mRNA levels were
detected in hepatocytes, biliary epithelial cells, sinusoidal endothelial cells, Kupffer cells,
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pit cells, and hepatic oval cells (Chen, Xu, Zhang, & Ma, 2010). It is also possible that
MCP-1 production could be attributed to inflammatory cells that infiltrate the liver after
PH, such as bone marrow-derived monocytes/macrophages. In fact, an intriguing report
by Crane et al. (2009) indicates that F4/80+ bone marrow cells are an abundant source of
MCP-1, as well as MCP-3 and MCP-5, during infection with murine cytomegalovirus
(Crane et al., 2009). Hence, during PH-induced liver regeneration, bone-marrow-derived
monocytes could be an important source of MCP-1 in the bone marrow, during transit to
the liver, or upon infiltration into hepatic tissue.
MCP-1 expression has been shown to directly correlate with the number of
infiltrating monocytes and macrophages in the liver (Marra et al., 1998), and inactivation
of MCP-1 reportedly attenuates liver injury by inhibiting macrophage recruitment
(Imamura et al., 2005; Marra et al. 2008, Zamara et al., 2007). However, we found no
difference in expression of the macrophage marker F4/80 in wild-type and MCP-1
knockout mice. Furthermore, plasma levels of TNFα and IL-6 were also similar, which
indicates that macrophage activation was likely unaffected by the absence of MCP-1. IL6 has been studied extensively as an important initiator of hepatocyte proliferation after
PH, as regeneration is impaired and survival is reduced in IL-6-deficient mice subjected
to PH (Blindenbacher et al., 2003; Kovalovich et al., 2000). Studies with IL-6 bone
marrow chimeric mice demonstrate that, during liver regeneration, IL-6 is produced by
bone marrow-derived, resident macrophages, rather than bone-marrow-derived stem cells
that enter the liver and differentiate into parenchymal cells (Aldeguer et al., 2002). This
leads us to conclude that MCP-1 is probably not required for Kupffer cell activation after
PH.

32
During the priming phase of regeneration, IL-6 activates the signal transducer and
activator of transcription-3 (STAT3) pathway, which upregulates immediate-early gene
expression in hepatocytes and promotes responsiveness to growth factors (Li, Liang,
Kellendonk, Poli, & Taub, 2002; Terui & Ozaki, 2005). Given that levels of STAT3
phosphorylation were similar in wild-type and MCP-1 knockout mice, it stands to reason
that hepatocyte priming proceeds sufficiently despite the absence of MCP-1.
Furthermore, continuous and pulse BrdU labeling revealed similar levels of hepatocyte
proliferation in wild-type and MCP-1 knockout mice, which confirms that MCP-1 is
dispensable for liver regeneration.
Results from this study demonstrate comparable numbers of CCR2+ cells in the
liver of wild-type and MCP-1 knockout mice. We speculate that this was due to the
activity of other CCR2 ligands, such as MCP-3 or MCP-5, which could essentially
compensate for the absence of MCP-1. However, the observation that liver regeneration
was not overtly suppressed in CCR2 knockout mice renders this notion somewhat
irrelevant. In CCR2 KO mice, hepatocyte proliferation was suppressed 36 hr post-PH.
However, this did not coincide with decreased liver-body weight ratios, and BrdU
incorporation was comparable between CCR2 KO and wild-type mice at 48 hr post-PH.
The suppression at 36 hr may result from diminished macrophage activity in the absence
of CCR2, either through decreased monocyte recruitment to the liver or reduced
activation of resident Kupffer cells. Crane et al. (2009) demonstrated that CCR2
activation in the bone marrow initiates the egress of CCR2+ monocytes into the
circulation and to the liver. Furthermore, they demonstrated that the CCR2+ Ly6Chigh
inflammatory subpopulation of monocytes/macrophages accumulated in the bone marrow
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during MCMV infection, and that the number of inflammatory monocytes/macrophages
was diminished in CCR2-deficient mice. Hence, it is possible that monocyte recruitment
and/or macrophage activation is reduced in CCR2 knockout mice, leading to a transient
suppression of hepatocyte proliferation. Results from this study highlight the need to
further investigate CCR2 signaling, as well as other chemokines receptors expressed in
the bone marrow, as this could be a driving force that initiates the release of
inflammatory monocytes/macrophages that are destined for the regenerating liver.
Future studies could include elucidating the role of CCR2+ cells in the
regenerative process by isolating them and studying gene expression at various times
following PH. Furthermore, the heterogeneity among this CCR2+ population can be
further characterized using flow cytometry to determine if a specific subpopulation is
critical to the regenerative process. Results from this project further our understanding of
MCP-1/CCR2 signaling as it relates to inflammation and injury in the liver. This is an
important endeavor for advancing our knowledge of liver disease and developing new
therapeutic strategies to enhance recovery from liver disease.
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